AU2003228263A1 - THE EFFERVESCENT PHARMACEUTICAL DOSAGE FORM OF ESTERS AND ESTER SALTS OF 6 Alpha METHYLPREDNISOLONE SUCCINATE, PROCEDURE FOR ITS OBTAINING AND APPLICATION - Google Patents

THE EFFERVESCENT PHARMACEUTICAL DOSAGE FORM OF ESTERS AND ESTER SALTS OF 6 Alpha METHYLPREDNISOLONE SUCCINATE, PROCEDURE FOR ITS OBTAINING AND APPLICATION

Info

Publication number
AU2003228263A1
AU2003228263A1 AU2003228263A AU2003228263A AU2003228263A1 AU 2003228263 A1 AU2003228263 A1 AU 2003228263A1 AU 2003228263 A AU2003228263 A AU 2003228263A AU 2003228263 A AU2003228263 A AU 2003228263A AU 2003228263 A1 AU2003228263 A1 AU 2003228263A1
Authority
AU
Australia
Prior art keywords
alpha
esters
procedure
obtaining
application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003228263A
Inventor
Branka Palurovic
Slobodan Petrovic
Ljiljana Solomun
Biljana Stupar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hemofarm Koncern Ad Pharmaceutical And Chemical Industry
Original Assignee
HEMOFARM KONCERN A D PHARMACEU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HEMOFARM KONCERN A D PHARMACEU filed Critical HEMOFARM KONCERN A D PHARMACEU
Publication of AU2003228263A1 publication Critical patent/AU2003228263A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
AU2003228263A 2002-03-29 2003-03-28 THE EFFERVESCENT PHARMACEUTICAL DOSAGE FORM OF ESTERS AND ESTER SALTS OF 6 Alpha METHYLPREDNISOLONE SUCCINATE, PROCEDURE FOR ITS OBTAINING AND APPLICATION Abandoned AU2003228263A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
YUP-235/02 2002-03-29
YUP023502 2002-03-29
PCT/YU2003/000010 WO2003082251A2 (en) 2002-03-29 2003-03-28 THE EFFERVESCENT PHARMACEUTICAL DOSAGE FORM OF ESTERS AND ESTER SALTS OF 6 α METHYLPREDNISOLONE SUCCINATE, PROCEDURE FOR ITS OBTAINING AND APPLICATION

Publications (1)

Publication Number Publication Date
AU2003228263A1 true AU2003228263A1 (en) 2003-10-13

Family

ID=28675908

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003228263A Abandoned AU2003228263A1 (en) 2002-03-29 2003-03-28 THE EFFERVESCENT PHARMACEUTICAL DOSAGE FORM OF ESTERS AND ESTER SALTS OF 6 Alpha METHYLPREDNISOLONE SUCCINATE, PROCEDURE FOR ITS OBTAINING AND APPLICATION

Country Status (2)

Country Link
AU (1) AU2003228263A1 (en)
WO (1) WO2003082251A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103159817A (en) * 2011-12-13 2013-06-19 辽宁海思科制药有限公司 Preparation method for methylprednisolone succinate
DE102018130836B4 (en) 2018-12-04 2023-08-10 Galenpharma Gmbh Process for preparing lyophilized sodium methylprednisolone succinate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3719599A (en) * 1969-11-25 1973-03-06 Lepetit Spa Solid lubricant composition and method of preparation
WO1997020578A1 (en) * 1995-12-04 1997-06-12 University Of Miami Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance

Also Published As

Publication number Publication date
WO2003082251A3 (en) 2004-03-18
WO2003082251A2 (en) 2003-10-09

Similar Documents

Publication Publication Date Title
EP1479666A4 (en) Ester compound and medicinal use thereof
AU2003248703A1 (en) Stabilized retinol for cosmetic dermatological, and pharmaceutical compositions, and use thereof
AU2003234231A1 (en) New polyarylates for drug delivery and tissue engineering
IL216931A (en) Pharmaceutical formulation comprising azelastine and a mometasone ester
AU2003222642A1 (en) Aerosol generator for drug formulation and methods of generating aerosol
AU2003239609A1 (en) 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
AU2003267203A1 (en) Method for administering thermotherapy to prevent the growth of tumors
AU2003223930A1 (en) Pharmaceutical use of boronic acids and esters thereof
AU2003222083A1 (en) Acid and ester compounds and methods of using the same
AU2003276572A1 (en) Pharmaceutical dosage forms of biguanide-sulfonylurea combinations
AU2002368245A1 (en) Matrix type patch for transdermal administration of vitamin d analog and the use thereof
IL162937A0 (en) Pravastatin pharmaceutical formulations and methods of their use
AU2003246567A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
AU2003290799A1 (en) 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
AU2001258395A1 (en) Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
AU2003232257A1 (en) Resorbable pharmaceutical formulation for the continuous release of thrombin
AU2003246566A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
AU2001263200A1 (en) Gamma irradiation of protein-based pharmaceutical products
AU2003228263A1 (en) THE EFFERVESCENT PHARMACEUTICAL DOSAGE FORM OF ESTERS AND ESTER SALTS OF 6 Alpha METHYLPREDNISOLONE SUCCINATE, PROCEDURE FOR ITS OBTAINING AND APPLICATION
AU2003284942A1 (en) Oral extended release tablets and methods of making and using the same
AU2003291238A1 (en) Moringa esters and cosmetic and pharmaceutical preparations and methods of manufacture thereof
AU2003256157A1 (en) Oral dosage forms of water insoluble drugs and methods of making the same
AU2003280387A1 (en) Pharmaceutical formulation comprising azithrocycin monohydrate
AU2003251303A1 (en) Pharmaceutical products and methods of manufacture
AU2002252610A1 (en) Ultrasonic profiling of medicament administration into tissue

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase